Nanobody binding to a conserved epitope promotes norovirus particle disassembly

Journal of Virology

Volumn 89, Issue 5, 2015, Pages 2718-2730

  Koromyslova, Anna D ^a   Hansman, Grant S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; NANOBODY; NANOBODY 25; NANOBODY 85; UNCLASSIFIED DRUG; PROTEIN BINDING; VIRUS ANTIBODY;

ANTIBODY COMBINING SITE; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; CRYOELECTRON MICROSCOPY; CRYSTAL STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HINGE REGION; IN VITRO STUDY; NONHUMAN; NOROVIRUS; PROTEIN DOMAIN; VIRUS DETECTION; VIRUS PARTICLE; VIRUS STRAIN; X RAY CRYSTALLOGRAPHY; CHEMISTRY; DRUG EFFECTS; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN CONFORMATION; ULTRASTRUCTURE; VIRION; VIRUS UNCOATING;

MIRIDAE; NOROVIRUS; RNA VIRUSES;

ANTIBODIES, VIRAL; CAPSID PROTEINS; CRYOELECTRON MICROSCOPY; CRYSTALLOGRAPHY, X-RAY; EPITOPES; HUMANS; NOROVIRUS; PROTEIN BINDING; PROTEIN CONFORMATION; SINGLE-DOMAIN ANTIBODIES; VIRION; VIRUS UNCOATING;

EID: 84922971779     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03176-14     Document Type: Article

References (42)

1. Hansman GS, Natori K, Shirato-Horikoshi H, Ogawa S, Oka T, Katayama K, Tanaka T, Miyoshi T, Sakae K, Kobayashi S, Shinohara M, Uchida K, Sakurai N, Shinozaki K, Okada M, Seto Y, Kamata K, Nagata N, Tanaka K, Miyamura T, Takeda N. 2006. Genetic and antigenic diversity among noroviruses. J Gen Virol 87:909-919. http://dx.doi.org/10.1099/vir.0.81532-0.
2. Vinje J. 2 July 2014. Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol http://dx.doi.org/10.1128/JCM.01535-14.
3. Kroneman A, Vega E, Vennema H, Vinje J, White PA, Hansman G, Green K, Martella V, Katayama K, Koopmans M. 2013. Proposal for a unified norovirus nomenclature and genotyping. Arch Virol 158:2059-2068. http://dx.doi.org/10.1007/s00705-013-1708-5.
4. Siebenga JJ, Vennema H, Renckens B, de Bruin E, van der Veer B, Siezen RJ, Koopmans M. 2007. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol 81:9932-9941. http://dx.doi.org/10.1128/JVI.00674-07.
5. Debbink K, Lindesmith LC, Donaldson EF, Costantini V, Beltramello M, Corti D, Swanstrom J, Lanzavecchia A, Vinje J, Baric RS. 2013. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis 208:1877-1887. http://dx.doi.org/10.1093/infdis/jit370.
6. Lindesmith LC, Debbink K, Swanstrom J, Vinje J, Costantini V, Baric RS, Donaldson EF. 2012. Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002. J Virol 86:873-883. http://dx.doi.org/10.1128/JVI.06200-11.
7. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, Vinje J, Baric RS. 2008. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 5:e31. http://dx.doi.org/10.1371/journal.pmed.0050031.
8. Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR, Grau KR, Gonzalez-Hernandez MB, Iovine NM, Wobus CE, Vinje J, Tibbetts SA, Wallet SM, Karst SM. 2014. Enteric bacteria promote human and mouse norovirus infection of B cells. Science 346:755-759. http://dx.doi.org/10.1126/science.1257147.
9. Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, Estes MK. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science 286:287-290. http://dx.doi.org/10.1126/science.286.5438.287.
10. Katpally U, Voss NR, Cavazza T, Taube S, Rubin JR, Young VL, Stuckey J, Ward VK, Virgin HW, Wobus CE, Smith TJ. 2010. Highresolution cryo-electron microscopy structures of murine norovirus 1 and rabbit hemorrhagic disease virus reveal marked flexibility in the receptor binding domains. J Virol 84:5836-5841. http://dx.doi.org/10.1128/JVI.00314-10.
11. Hansman GS, Taylor DW, McLellan JS, Smith TJ, Georgiev I, Tame JR, Park SY, Yamazaki M, Gondaira F, Miki M, Katayama K, Murata K, Kwong PD. 2012. Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle. J Virol 86:3635-3646. http://dx.doi.org/10.1128/JVI.06868-11.
12. Smith TJ. 2011. Structural studies on antibody recognition and neutralization of viruses. Curr Opin Virol 1:150-156. http://dx.doi.org/10.1016/j.coviro.2011.05.020.
13. Parker TD, Kitamoto N, Tanaka T, Hutson AM, Estes MK. 2005. Identification of genogroup I and genogroup II broadly reactive epitopes on the norovirus capsid. J Virol 79:7402-7409. http://dx.doi.org/10.1128/JVI.79.12.7402-7409.2005.
14. Shiota T, Okame M, Takanashi S, Khamrin P, Takagi M, Satou K, Masuoka Y, Yagyu F, Shimizu Y, Kohno H, Mizuguchi M, Okitsu S, Ushijima H. 2007. Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope. J Virol 81:12298-12306. http://dx.doi.org/10.1128/JVI.00891-07.
15. Hansman GS, Doan LT, Kguyen TA, Okitsu S, Katayama K, Ogawa S, Natori K, Takeda N, Kato Y, Nishio O, Noda M, Ushijima H. 2004. Detection of norovirus and sapovirus infection among children with gastroenteritis in Ho Chi Minh City, Vietnam. Arch Virol 149:1673-1688. http://dx.doi.org/10.1007/s00705-004-0345-4.
16. Koho T, Huhti L, Blazevic V, Nurminen K, Butcher SJ, Laurinmäki P, Kalkkinen N, Rönnholm G, Vesikari T, Hytönen VP, Kulomaa MS. 2012. Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus. J Virol Methods 179:1-7. http://dx.doi.org/10.1016/j.jviromet.2011.05.009.
17. Hansman GS, Biertumpfel C, Georgiev I, McLellan JS, Chen L, Zhou T, Katayama K, Kwong PD. 2011. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. J Virol 85:6687-6701. http://dx.doi.org/10.1128/JVI.00246-11.
18. Hansman GS, Guntapong R, Pongsuwanna Y, Natori K, Katayama K, Takeda N. 2006. Development of an antigen ELISA to detect sapovirus in clinical stool specimens. Arch Virol 151:551-561. http://dx.doi.org/10.1007/s00705-005-0630-x.
19. Hansman GS, Katayama K, Maneekarn N, Peerakome S, Khamrin P, Tonusin S, Okitsu S, Nishio O, Takeda N, Ushijima H. 2004. Genetic diversity of norovirus and sapovirus in hospitalized infants with sporadic cases of acute gastroenteritis in Chiang Mai, Thailand. J Clin Microbiol 42:1305-1307. http://dx.doi.org/10.1128/JCM.42.3.1305-1307.2004.
20. Bull RA, Tu ET, McIver CJ, Rawlinson WD, White PA. 2006. Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis. J Clin Microbiol 44:327-333. http://dx.doi.org/10.1128/JCM.44.2.327-333.2006.
21. Kabsch W. 1993. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J Appl Crystallogr 26:795-800. http://dx.doi.org/10.1107/S0021889893005588.
22. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J Appl Crystallogr 40: 658-674. http://dx.doi.org/10.1107/S0021889807021206.
23. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486-501. http://dx.doi.org/10.1107/S0907444910007493.
24. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung L-W, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221. http://dx.doi.org/10.1107/S0907444909052925.
25. Morris AL, MacArthur MW, Hutchinson EG, Thornton JM. 1992. Stereochemical quality of protein structure coordinates. Proteins 12:345-364. http://dx.doi.org/10.1002/prot.340120407.
26. Chen VB, Arendall WB, III, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. 2010. Mol-Probity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12-21. http://dx.doi.org/10.1107/S0907444909042073.
27. Krissinel E, Henrick K. 2007. Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774-797. http://dx.doi.org/10.1016/j.jmb.2007.05.022.
28. Spinelli S, Frenken L, Bourgeois D, de Ron L, Bos W, Verrips T, Anguille C, Cambillau C, Tegonil M. 1996. The crystal structure of a llama heavy chain variable domain. Nat Struct Biol 3:752-757. http://dx.doi.org/10.1038/nsb0996-752.
29. Desmyter A, Transue TR, Ghahroudi MA, Thi MH, Poortmans F, Hamers R, Muyldermans S, Wyns L. 1996. Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat Struct Biol 3:803-811. http://dx.doi.org/10.1038/nsb0996-803.
30. Helma J, Schmidthals K, Lux V, Nuske S, Scholz AM, Kraüsslich HG, Rothbauer U, Leonhardt H. 2012. Direct and dynamic detection of HIV-1 in living cells. PLoS One 7:e50026. http://dx.doi.org/10.1371/journal.pone.0050026.
31. De Meyer T, Muyldermans S, Depicker A. 2014. Nanobody-based products as research and diagnostic tools. Trends Biotechnol 32:263-270. http://dx.doi.org/10.1016/j.tibtech.2014.03.001.
32. Goldman ER, Anderson GP, Liu JL, Delehanty JB, Sherwood LJ, Osborn LE, Cummins LB, Hayhurst A. 2006. Facile generation of heatstable antiviral and antitoxin single domain antibodies from a semisynthetic llama library. Anal Chem 78:8245-8255. http://dx.doi.org/10.1021/ac0610053.
33. Sherwood LJ, Osborn LE, Carrion R, Jr, Patterson JL, Hayhurst A. 2007. Rapid assembly of sensitive antigen-capture assays for Marburg virus, using in vitro selection of llama single-domain antibodies, at biosafety level. 4. J Infect Dis 196(Suppl 2):S213-S219. http://dx.doi.org/10.1086/520586.
34. Fatima A, Wang H, Kang K, Xia L, Wang Y, Ye W, Wang J, Wang X. 2014. Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis. PLoS One 9:e95263. http://dx.doi.org/10.1371/journal.pone.0095263.
35. Ibanez LI, De Filette M, Hultberg A, Verrips T, Temperton N, Weiss RA, Vandevelde W, Schepens B, Vanlandschoot P, Saelens X. 2011. Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. J Infect Dis 203:1063-1072. http://dx.doi.org/10.1093/infdis/jiq168.
36. Wei G, Meng W, Guo H, Pan W, Liu J, Peng T, Chen L, Chen CY. 2011. Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein. PLoS One 6:e28309. http://dx.doi.org/10.1371/journal.pone.0028309.
37. Hinz A, Lutje Hulsik D, Forsman A, Koh WW, Belrhali H, Gorlani A, de Haard H, Weiss RA, Verrips T, Weissenhorn W. 2010. Crystal structure of the neutralizing llama VHH D7 and its mode of HIV-1 gp120 interaction. PLoS One 5:e10482. http://dx.doi.org/10.1371/journal.pone.0010482.
38. De Meyer T, Muyldermans S, Depicker A. 2014. Nanobody-based products as research and diagnostic tools. Trends Biotechnol 32:263-270. http://dx.doi.org/10.1016/j.tibtech.2014.03.001.
39. de Bruin E, Duizer E, Vennema H, Koopmans MP. 2006. Diagnosis of norovirus outbreaks by commercial ELISA or RT-PCR. J Virol Methods 137:259-264. http://dx.doi.org/10.1016/j.jviromet.2006.06.024.
40. Burton-MacLeod JA, Kane EM, Beard RS, Hadley LA, Glass RI, Ando T. 2004. Evaluation and comparison of two commercial enzyme-linked immunosorbent assay kits for detection of antigenically diverse human noroviruses in stool samples. J Clin Microbiol 42:2587-2595. http://dx.doi.org/10.1128/JCM.42.6.2587-2595.2004.
41. Kele B, Lengyel G, Deak J. 2011. Comparison of an ELISA and two reverse transcription polymerase chain reaction methods for norovirus detection. Diagn Microbiol Infect Dis 70:475-478. http://dx.doi.org/10.1016/j.diagmicrobio.2011.04.002.
42. Singh BK, Leuthold MM, Hansman GS. 2015. Human noroviruses' fondness for histo-blood group antigens. J Virol 89:2024-2040. http://dx.doi.org/10.1128/JVI.02968-14.